Related Experiment Video
Updated: Jun 26, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome
Céline Bailly-Botuha1, Virginie Colomb, Elizabeth Thioulouse
1Gastroentérologie et Nutrition Pédiatriques, Hôpital Armand-Trousseau, APHP, Paris 75012, France.
Insights
Plasma citrulline assays can monitor intestinal adaptation in children with short bowel syndrome. Levels correlate with bowel length and improve when patients are weaned from parenteral nutrition.
Area of Science:
- Pediatric Gastroenterology
- Intestinal Failure Research
- Biomarker Development
Background:
- Plasma citrulline reflects enterocyte mass in intestinal failure.
- Limited data exist on its utility in pediatric short bowel syndrome (SBS).
Purpose of the Study:
- To evaluate the role of plasma citrulline assays in monitoring intestinal adaptation in children with SBS.
Main Methods:
- Prospective study of 31 children with SBS.
- Serial plasma citrulline measurements correlated with short bowel length and parenteral nutrition (PN) dependence.
Main Results:
- Plasma citrulline positively correlated with residual small bowel length.
- Citulline levels negatively correlated with intestinal failure severity.
- Citulline increased in patients weaned from PN, remaining low in those dependent on PN.
- No weaned patients had <40 cm bowel and <11 microM citrulline.
Conclusions:
- Serial plasma citrulline assays are valuable for monitoring residual small bowel adaptation in pediatric SBS.
- Citrulline levels can help assess readiness for PN weaning.
Abstract:
Plasma citrulline was recently shown to reflect the residual functional enterocyte mass in various situations characterized by intestinal failure. However, few data are available in children with short bowel syndrome. The objective of this study was to assess the value of citrulline assays in this situation. Prospective plasma citrulline assays were performed in 31 children with short bowel syndrome. Median age was 16 mo (range, 1 mo to 15 y), and median follow-up was 14 mo (6-40 mo). The energy supplied by parenteral nutrition (PN), served to assess intestinal failure severity. Plasma citrulline at inclusion showed a positive correlation with residual short bowel length. Subsequent values correlated negatively with intestinal failure severity. Plasma citrulline increased over time during or after weaning from PN (from 15.8 +/- 11.5 microM to 19.3 +/- 3.8 microM) but remained stable and low in patients who continued to need PN (6.5 +/- 3.0 microM at inclusion and 7.7 +/- 6.0 microM at last follow-up). No weaned patients had a residual short bowel length less than 40 cm and plasma citrulline less than 11 microM. Our findings constitute the first evidence that serial plasma citrulline assays help to monitor residual small bowel adaptation in children.
More Related Videos
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Serum Studies: Renal Function Tests

